ESTRO 2024 - Abstract Book

S2784

Interdisciplinary - Health economics & health services research

ESTRO 2024

Extreme hypofractionated radiation therapy for low and intermediate prostate cancer patients is more cost effective in terms of timing and economics in comparison with other fractionation schedules. Toxicity was not worse in comparison with other fractionations

Keywords: prostate cancer, cost, extreme hypofractionation

796

Digital Poster

Travel distance patterns of palliative radiotherapy patients in Victoria, Australia

Maike Trommer 1,2,3 , Piers Gillett 4 , Karen Trapani 4 , Colin Hornby 5 , Dishan Herath 5,6 , Karla Gough 5,7 , Keith Donohoe 8 , Phillip Tran 9 , Maarten Ijzerman 10 , Fanny Franchini 4 , Richard Khor 1,11,12 1 Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, Department of Radiation Oncology, Melbourne, Australia. 2 University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology, Cologne, Germany. 3 University Hospitals Aachen Bonn Cologne Dusseldorf, Center for Integrated Oncology (CIO), Cologne, Germany. 4 University of Melbourne, Cancer Health Services Research (CHSR), Melbourne, Australia. 5 Peter MacCallum Cancer Centre, Division of Radiation Oncology, Melbourne, Australia. 6 Western Health, Cancer Services, Melbourne, Australia. 7 University of Melbourne, Department of Surgery, Melbourne, Australia. 8 Royal Melbourne Hospital, Victorian Comprehensive Cancer Centre Alliance, Melbourne, Australia. 9 Peter MacCallum Cancer Centre, Department of Radiation Oncology, Melbourne, Australia. 10 University of Melbourne, Cancer Health Services Research, Melbourne, Australia. 11 Monash University, Department of Medical Imaging and Radiation Sciences, Melbourne, Australia. 12 La Trobe University, School of Molecular Sciences, Melbourne, Australia Palliative radiotherapy (PRT) plays a major role in cancer care. Approximately 50% of prescribed radiotherapy is given in palliative indication for people with incurable cancer to reduce symptoms like pain, obstruction or bleeding with minimal toxic effects. Administering radiotherapy demands specialised healthcare facilities equipped with linear accelerators (Linacs). In Victoria, Australia, numerous Linacs are available to treat a diverse range of radiotherapy indications. Research has shown clinical but also non-clinical barriers to receive PRT including geographical factors. There seems to be an inverse association between living further from a radiotherapy centre and being likely to receive PRT in the Global North countries 1 . Using a state-wide linked dataset, we examined the travel distance of palliative cancer patients treated with PRT in Victoria, Australia, relative to their home address over a nine-year period. This study aims to assess what travel distance palliative cancer patients have to undertake to receive treatment across tumour types and sex and to identify and quantify excess travel distances. Purpose/Objective:

Material/Methods: